Filtered By:
Vaccination: Influenza Vaccine
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 1458 results found since Jan 2013.
Acute Retinal Pigment Epitheliitis following Vaccination
We present a rare case of acute retinal pigment epitheliitis (ARPE) following vaccination. An 18-year-old Japanese man visited our hospital with a 5-day history of a central scotoma in the right eye. He had received the second dose of coronavirus disease 2019 vaccination (BNT162b2 mRNA, Pfizer-BioNTech) 1 month prior, following which he developed a low-grade fever of 37.3 –37.5°C for 2 days accompanied by joint pain. Although he had received influenza vaccination 5 days prior to this presentation, no systemic symptoms other than injection site pain were observed. Blood test results were unremarkable. Ophthalmological ex...
Source: Case Reports in Ophthalmology - November 10, 2022 Category: Opthalmology Source Type: research
TWiV 951: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses Influenza incidence and vaccine effectiveness during the southern hemisphere influenza season in Chile, Nirsevimab for prevention of RSV infection in healthy late-preterm and term infants, severe Monkeypox in hospitalized patients, reinfections with different SARS-CoV-2 Omicron subvariants, impact of community masking on COVID-19 in Bangladesh, unadjuvanted intranasal spike vaccine elicits protective […]
Source: virology blog - November 5, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern Source Type: blogs
IJERPH, Vol. 19, Pages 14392: Short and Long-Term Wellbeing of Children following SARS-CoV-2 Infection: A Systematic Review
Christa Scheidt-Nave
Post-COVID conditions in children and adolescents were mostly investigated as the incidence of individual or clusters of symptoms. We aimed to describe the findings of studies assessing key outcomes related to global wellbeing and recovery in children and adolescents from a public health perspective. We searched the Cochrane COVID-19 Study Register and WHO COVID-19 Global literature on coronavirus disease database on 5 November 2021 and tracked ongoing studies published after this date. We included observational studies on children and adolescents with a follow-up greater than 12 weeks and focused...
Source: International Journal of Environmental Research and Public Health - November 3, 2022 Category: Environmental Health Authors: Juan Victor Ariel Franco Luis Ignacio Garegnani Gisela Viviana Oltra Maria-Inti Metzendorf Leonel Fabrizio Trivisonno Nadia Sgarbossa Denise Ducks Katharina Heldt Rebekka Mumm Benjamin Barnes Christa Scheidt-Nave Tags: Systematic Review Source Type: research
Chewing to curb COVID
Penn Medicine will conduct a new clinical trial to evaluate the safety and efficacy of a chewing gum designed by School of Dental Medicine researchers to trap SARS-CoV-2 in the saliva. Chewing gum tablets containing plant material laced with the ACE2 protein are being evaluated in a clinical trial to see if they are safe and effective in trapping SARS-CoV-2 in the saliva. (Image: Kevin Monko/Penn Dental Medicine) A recently launched clinical trial at Penn Medicine will evaluate a new chewing gum designed by School of Dental Medicine researchers to trap SARS-CoV-2 in the saliva, potentially blocking transmission of COVID-19...
Source: Dental Technology Blog - November 2, 2022 Category: Dentistry Source Type: news
Why the U.S. Doesn ’t Have a Nasal Vaccine for COVID-19
The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting people from getting sick with COVID-19, they are less able to block infection. In order to put the pandemic behind us, the world will need a way to stop infections and spread of the virus. That’s where a different type of vaccine, one that works at the places where the virus gets into the body, will likely prove useful.
Here, though, the U.S. is losing its edge. In September, India approved a nasal COVID-19 vacc...
Source: TIME: Health - October 31, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Virus-CKB 2.0: Viral-Associated Disease-Specific Chemogenomics Knowledgebase
ACS Omega. 2022 Oct 10;7(42):37476-37484. doi: 10.1021/acsomega.2c04258. eCollection 2022 Oct 25.ABSTRACTTransmissible and infectious viruses can cause large-scale epidemics around the world. This is because the virus can constantly mutate and produce different variants and subvariants to counter existing treatments. Therefore, a variety of treatments are urgently needed to keep up with the mutation of the viruses. To facilitate the research of such treatment, we updated our Virus-CKB 1.0 to Virus-CKB 2.0, which contains 10 kinds of viruses, including enterovirus, dengue virus, hepatitis C virus, Zika virus, herpes simplex...
Source: Herpes - October 31, 2022 Category: Infectious Diseases Authors: Yixuan Hao Maozi Chen Yasmin Othman Xiang-Qun Xie Zhiwei Feng Source Type: research
TWiV 949: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses progress toward poliomyelitis eradication in Pakistan, polio by the numbers , influenza and COVID-19 vaccination coverage among health care personnel, phase 1/2a safety and immunogenicity of an adenovirus 26 vector RSV vaccine encoding prefusion F in adults 18–50 years and RSV seropositive children 12–24 months, receipt of first and second doses of JYNNEOS vaccine for prevention of Monkeypox, distinguishing SARS-CoV-2 persistence and reinfection, Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages, association between regular physical activity a...
Source: virology blog - October 29, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern Source Type: blogs
IJERPH, Vol. 19, Pages 14074: Mortality Risk Factors for Coronavirus Infection in Hospitalized Adults in Brazil: A Retrospective Cohort Study
Conclusions: Our results illustrate the severity of the COVID-19 pandemic in Brazil and reinforce that policies and practices to deal with this disease should focus on groups and regions with higher risk, whereas public policies should promote nonpharmacological measures and vaccination in the Brazilian population.
Source: International Journal of Environmental Research and Public Health - October 28, 2022 Category: Environmental Health Authors: Rafael Alves Guimar ães Raquel Silva Pinheiro Hellen da Silva Cintra de Paula Lyriane Apolin ário de Araújo Ingrid Aline de Jesus Gon çalves Charlise Fortunato Pedroso Adriana Oliveira Guilarde Geraldo Andrade de Oliveira Karla de Aleluia Batista Tags: Article Source Type: research
A ‘Tripledemic’? Flu, R.S.V. and Covid May Collide This Winter, Experts Say
Flu cases are higher than usual for this time of year and are expected to soar in the coming weeks. Another virus, R.S.V., already is straining pediatric hospitals in some states.
Source: NYT Health - October 27, 2022 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Influenza Children and Childhood Coronavirus Omicron Variant Respiratory Syncytial Virus (RSV) Disease Rates United States your-feed-science Source Type: news
Atherosclerosis by Virus Infection-A Short Review
Biomedicines. 2022 Oct 19;10(10):2634. doi: 10.3390/biomedicines10102634.ABSTRACTAtherosclerosis manifests by the thickening of artery walls and their narrowed channels through the accumulation of plaque. It is one of the most important indicators of cardiovascular disease. It can be caused by various factors, such as smoking, a high cholesterol diet, hypertension, hyperglycemia, and genetic factors. However, atherosclerosis can also develop due to infection. It has been reported that some bacteria and viruses can cause the development of atherosclerosis. Examples of these viruses are influenza viruses, herpes viruses, hep...
Source: Herpes - October 27, 2022 Category: Infectious Diseases Authors: Seang-Hwan Jung Kyung-Tae Lee Source Type: research
A ‘Tripledemic’? Flu and Other Infections Return as Covid Cases Rise
Flu cases are higher than usual for this time of year and are expected to soar in the coming weeks. A third virus, R.S.V., is straining pediatric hospitals in some states.
Source: NYT Health - October 23, 2022 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Vaccination and Immunization Coronavirus (2019-nCoV) Influenza Children and Childhood Coronavirus Omicron Variant Respiratory Syncytial Virus (RSV) Disease Rates Source Type: news
